Nrf2 activator for the treatment of kidney diseases

Explore this paper's citation graph

Summary

The Kelch‐like ECH‐associated protein 1‐nuclear factor erythroid 2‐related factor 2 (Keap1‐Nrf2) system has drawn much attention in recent years for its anti‐oxidative and anti‐inflammatory properties, and its pharmacological potential for treatment of kidney diseases is being widely investigated in both clinical and non‐clinical studies.

Type
review
Published
2018-12-01
Cited by
60
References
71
Access
Open access

Keywords

Activator (genetics), Kidney, Medicine, Intensive care medicine, Computational biology

References

Cited by

Related papers